Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and tolerability of nivolumab with and without ipilimumab in combination with Trans-arterial ChemoEmbolization (TACE) to TACE alone in participants with intermediate liver cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04340193
Study type Interventional
Source Bristol-Myers Squibb
Contact
Status Terminated
Phase Phase 3
Start date September 15, 2020
Completion date December 12, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06144827 - A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer N/A
Terminated NCT00669136 - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma Phase 1
Completed NCT01929902 - Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery
Completed NCT03586050 - Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea N/A